Is Grocery Chain's FCA Win in the Bag?
Client Alert | 1 min read | 04.20.18
On March 22, 2018, an Indiana state trial court dismissed a qui tam action alleging that a large grocery chain knowingly failed to collect and remit state sales tax on hundreds of goods. State of Indiana ex. rel Harmeyer v. The Kroger Co. et al. Under Indiana law, the state’s gross retail tax does not apply to “food and food ingredients,” but it does apply to candy, soft drinks, dietary supplements, and prepared foods. Relator claimed 1,400 food items were mischaracterized as tax-exempt, for example, claiming protein bars are taxable candy rather than nontaxable food.
The judge held that the complaint failed to identify any particular false statement, noting also that the relator, whose similar case against a grocer in another state had been dismissed, was not an employee of the grocery chain, had no inside knowledge of what took place within the company, and merely presumed that the defendant’s characterization of the items as tax-exempt was false and done recklessly. The court could not determine whether the 1,400 items constituted a substantial percentage of the products sold by defendant, and therefore, even if they were mischaracterized, the court could not presume recklessness from that number. Last week, relator filed his appeal.
The dismissal is a blow to serial qui tam relators who, with no inside information, bring claims against companies based solely on a presumption that they must be non-compliant with an industry regulation. The case also reflects an uptick in FCA litigation involving underpayment state taxes (previous post here). While the federal FCA bars tax-related actions (31 USC § 3729(d)), companies must still consider potential exposure in the jurisdictions that permit FCA suits arising from state tax matters.
Contacts
Insights
Client Alert | 6 min read | 04.29.26
CMS Seeks to Expand Interoperability Requirements to Drug Pre-Authorization (FAQ)
On April 10, 2026, the Centers for Medicare and Medicaid Services (CMS) issued a proposed rule (2026 CMS Interoperability Standards and Prior Authorization for Drugs, or CMS-0062-P) outlining the agency’s plans to impose new interoperability requirements on payors participating in certain Medicare and Medicaid programs. As described by the agency in a recent press release, the proposed rule “builds on” prior rulemaking by clarifying and enhancing interoperability requirements for payors’ prior authorization processes, specifically those associated with coverage requests for pharmaceutical therapies.
Client Alert | 8 min read | 04.27.26
Client Alert | 5 min read | 04.27.26
Drift Protocol Exploit: Why “Social Trust” Is the Newest Cybersecurity Gap
Client Alert | 4 min read | 04.27.26
Gaming Addiction Litigation: Turner v. Epic Games & Roblox and What It Means for the Industry

